FDA Inspection 857285 — North China Pharmaceutical Huasheng Co., LTD
The FDA completed an inspection of North China Pharmaceutical Huasheng Co., LTD on Nov 1, 2013 in Shijiazhuang. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Veterinary.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Nov 1, 2013
- Fiscal Year
- 2014
- Product Type
- Veterinary
- Project Area
- Pre-Approval Eval. of Animal Drugs and Food Additives
- Location
- Shijiazhuang (China)